Amgen to buy clinical stage biotech company Teneobio for $900M cash

The deal to buy Teneobio, which is developing treatments for cancer, autoimmunity and infectious diseases, includes future milestone payments worth up to $1.6 billion.

Source: bizjournals.com Health Care:Physician Practices headlines - July 27, 2021 Category: American Health Authors: I-Chun Chen Source Type: news